Generation Bio Co reports results for the quarter ended September 30 - Earnings Summary

Generation Bio Co reported an adjusted loss of 82 cents per share for the quarter ended September 30, an improvement from a loss of $2.30 per share a year ago. Revenue fell 78.9% to $1.59 million, below analyst expectations of $660,000. The company incurred a quarterly loss of $5.52 million, with shares down 14.2% this quarter and 50.5% year-to-date. Analysts maintain a "buy" rating, with a median 12-month price target of $13.50, indicating a potential upside of 61.1% from the last closing price of $5.25.